Clinical impact of a pharmacist-led inpatient anticoagulation service: a review of the literature
Authors:
Open Access
- 1 May 2016
- journal article
- review article
- Published by Taylor & Francis in Integrated Pharmacy Research and Practice
- Vol. ume 5, 53-63
Abstract
Background: Anticoagulant therapies provide management options for potentially life-threatening thromboembolic conditions. They also carry significant safety risks, requiring careful consideration of medication dose, close monitoring, and follow-up. Inpatients are particularly at risk, considering the widespread use of anticoagulants in hospitals. This has prompted the introduction of safety goals for anticoagulants in Canada and the USA, which recommend increased pharmacist involvement to reduce patient harm. The goal of this review is to evaluate the efficacy and safety of pharmacist-led inpatient anticoagulation services compared to usual or physician-managed care. Methods: This narrative review includes articles identified through a literature search of PubMed, Embase, and International Pharmaceutical Abstracts databases, as well as hand searches of the references of relevant articles. Full publications of pharmacist-managed inpatient anticoagulation services were eligible if they were published in English and assessed clinical outcomes. Results: Twenty-six studies were included and further divided into two categories: 1) autonomous pharmacist-managed anticoagulation programs (PMAPs) and 2) pharmacist recommendation. Pharmacist management of heparin and warfarin appears to result in improvements in some surrogate outcomes (international normalized ratio [INR] stability and time in INR goal range), while results for others are mixed (time to therapeutic INR, length of stay, and activated partial thromboplastin time [aPTT] measures). There is also some indication that PMAPs may be associated with reduced patient mortality. When direct thrombin inhibitors are managed by pharmacists, there seems to be a shorter time to therapeutic aPTT and a greater percentage of time in the therapeutic range, as well as a decrease in the frequency of medication errors. Pharmacist recommendation services have generally resulted in a greater time in therapeutic INR range, greater INR stability, decreased length of stay, and reduced major drug interactions, with no significant differences in safety outcomes. Conclusion: Pharmacist-led inpatient anticoagulation management seems to result in superior outcomes, as compared to usual or physician-managed care. This conclusion is limited by small, poorly designed studies lacking statistical power, focusing mainly on surrogate outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Evaluating Warfarin Management by Pharmacists in a Community Teaching HospitalThe Consultant Pharmacist, 2014
- Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous ThromboembolismPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Inpatient warfarin management: pharmacist management using a detailed dosing protocolJournal of Thrombosis and Thrombolysis, 2011
- Clinical and safety impact of an inpatient Pharmacist‐Directed anticoagulation serviceJournal of Hospital Medicine, 2011
- Clinical Outcomes and Pharmacists' Acceptance of a Community Hospital's Anticoagulation Management Service Utilizing Decentralized Clinical Staff PharmacistsAnnals of Pharmacotherapy, 2009
- Pharmacy-managed anticoagulation: Assessment of in-hospital efficacy and evaluation of financial impact and community acceptanceJournal of Thrombosis and Thrombolysis, 2006
- Development and Implementation of a Pharmacist-Managed Inpatient Warfarin ProtocolBaylor University Medical Center Proceedings, 2005
- Evaluation of warfarin dosing by pharmacists for elderly medical in-patientsPharmacy World & Science, 2004
- Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients.2003
- Pharmacist involvement with warfarin dosing for inpatients.International Journal of Clinical Pharmacy, 2001